NN7999-4031: A Non-Interventional Post-Authorisation Safety Study (PASS) in male haemophilia B patients receiving Nonacog Beta Pegol (N9-GP) prophylaxis treatment

First published 27/11/2018

Last updated 02/07/2024

EU PAS number:

EUPAS26592

Study

Ongoing

Documents

Study protocol

Initial protocol

4031-protocol-eu-pas-reg-redacted

English (426.11 KB - PDF)View document

Updated protocol

4031-protocol-eu-pas-reg-redacted-version-2.0

First published: 22/02/2024

English (458.26 KB - PDF)View document

Study results

Study report

4031 regulatory progress report pass progress report no.04 eu-pas-reg redacted

English (429.16 KB - PDF)View document

4031-eu-pass-progress-report-20191206

English (102.31 KB - PDF)View document

4031EU pass progress report no.02

English (349.97 KB - PDF)View document

_ Public Registration of Results Regulatory pass progress report redacted

English (315.53 KB - PDF)View document

Other information

Study, other information

4031-eu-pass-progress-report-20191206.pdf

English (102.31 KB - PDF)View document

4031EU pass progress report no.02.pdf

English (349.97 KB - PDF)View document

_ Public Registration of Results Regulatory pass progress report redacted.pdf

English (315.53 KB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs